Guojun Hou

731 total citations
20 papers, 319 citations indexed

About

Guojun Hou is a scholar working on Cancer Research, Molecular Biology and Rheumatology. According to data from OpenAlex, Guojun Hou has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Molecular Biology and 8 papers in Rheumatology. Recurrent topics in Guojun Hou's work include Systemic Lupus Erythematosus Research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Guojun Hou is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Guojun Hou collaborates with scholars based in China, United States and Japan. Guojun Hou's co-authors include Nan Shen, Huihua Ding, Jie Qian, Chao Yao, Yao Meng, Jiehua Wang, Ya Liu, Lingling Wu, Bo Qu and Yange Cui and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and Carcinogenesis.

In The Last Decade

Guojun Hou

17 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guojun Hou China 10 182 127 117 61 41 20 319
Sylvie Fabre France 10 81 0.4× 61 0.5× 57 0.5× 95 1.6× 35 0.9× 14 247
Diego Quinones Raffo United States 9 83 0.5× 41 0.3× 125 1.1× 38 0.6× 44 1.1× 17 304
Indu Raman United States 9 86 0.5× 31 0.2× 117 1.0× 114 1.9× 32 0.8× 18 281
Tarek I. Ahmed Egypt 10 191 1.0× 244 1.9× 34 0.3× 34 0.6× 28 0.7× 21 335
Marta Vidal Spain 6 296 1.6× 144 1.1× 64 0.5× 140 2.3× 12 0.3× 8 414
Amar Bhatnagar India 11 167 0.9× 46 0.4× 73 0.6× 62 1.0× 88 2.1× 23 359
Andrew Podd United States 7 73 0.4× 75 0.6× 304 2.6× 18 0.3× 85 2.1× 10 434
Seiji Segawa Japan 12 76 0.4× 24 0.2× 179 1.5× 78 1.3× 65 1.6× 17 320
Simanta Pathak United States 9 121 0.7× 30 0.2× 210 1.8× 70 1.1× 86 2.1× 12 371
Norzawani B Buang United Kingdom 5 116 0.6× 24 0.2× 223 1.9× 77 1.3× 34 0.8× 5 360

Countries citing papers authored by Guojun Hou

Since Specialization
Citations

This map shows the geographic impact of Guojun Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guojun Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guojun Hou more than expected).

Fields of papers citing papers by Guojun Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guojun Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guojun Hou. The network helps show where Guojun Hou may publish in the future.

Co-authorship network of co-authors of Guojun Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Guojun Hou. A scholar is included among the top collaborators of Guojun Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guojun Hou. Guojun Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Zhihua, Dai Dai, Nan Shen, et al.. (2024). Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLE. Lupus Science & Medicine. 11(1). e001065–e001065. 2 indexed citations
2.
Wu, Qiong, Lei Wei, Jianchun Sheng, et al.. (2024). miR-3154 promotes glioblastoma proliferation and metastasis via targeting TP53INP1. Cell Division. 19(1). 30–30.
3.
Zhang, Yutong, Guojun Hou, & Nan Shen. (2024). Non-coding DNA variants for risk in lupus. Best Practice & Research Clinical Rheumatology. 38(2). 101937–101937.
4.
Chen, Mengke, Yutong Zhang, Xuejiao Song, et al.. (2024). SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus. Acta Biochimica et Biophysica Sinica. 56(11). 1659–1672.
5.
Li, Wen, Guojun Hou, Dapeng Sun, et al.. (2023). Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. Experimental & Molecular Medicine. 55(11). 2390–2401. 26 indexed citations
6.
Gu, Shuangshuang, Jinsong Zhang, Huihua Ding, et al.. (2023). Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity. Arthritis & Rheumatology. 75(8). 1381–1394. 15 indexed citations
7.
Zhang, Yutong, Zhizhong Ye, Yuting Qin, et al.. (2023). Three‐Dimensional Chromosomal Landscape Revealing miR‐146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR‐Mediated Approach to Inhibit the Interferon Pathway. Arthritis & Rheumatology. 76(3). 384–395. 3 indexed citations
8.
Sun, Dapeng, Xiaojie Gan, Lei Liu, et al.. (2022). DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334. Cell Death and Disease. 13(5). 446–446. 16 indexed citations
9.
Hou, Guojun, et al.. (2022). Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease. Journal of Autoimmunity. 137. 102948–102948. 8 indexed citations
10.
Hou, Guojun, Tian Zhou, Ning Xu, et al.. (2022). Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus. Arthritis & Rheumatology. 75(4). 574–585. 16 indexed citations
11.
Zhang, Ping, et al.. (2022). miR-4461 inhibits liver cancer stem cells expansion and chemoresistance via regulating SIRT1. Carcinogenesis. 45(7). 463–474. 10 indexed citations
12.
Tian, Tao, Feng Xiao, Hongdong Li, et al.. (2021). Association between serum iron status and primary liver cancer risk: a Mendelian randomization analysis. Annals of Translational Medicine. 9(20). 1533–1533. 9 indexed citations
13.
Qiu, Rong, Xiang Yu, Li Wang, et al.. (2020). Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR-21–Peli1–c-Rel Pathway Prevents Autoimmunity. The Journal of Immunology. 204(12). 3160–3170. 19 indexed citations
14.
Wang, Li, Rong Qiu, Zhaoyang Zhang, et al.. (2020). The MicroRNA miR-22 Represses Th17 Cell Pathogenicity by Targeting PTEN-Regulated Pathways. ImmunoHorizons. 4(6). 308–318. 6 indexed citations
15.
Ye, Zhizhong, Lingling Wu, Chao Yao, et al.. (2019). Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis. Frontiers in Immunology. 10. 975–975. 57 indexed citations
16.
Wang, Jiehua, Min Dai, Yange Cui, et al.. (2018). Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP‐AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes. Arthritis & Rheumatology. 70(12). 2036–2045. 71 indexed citations
17.
Hou, Guojun, et al.. (2017). [Inhibitory effect of BEZ235 on human prostate carcinoma in vitro].. PubMed. 42(8). 869–873. 1 indexed citations
18.
Tang, Jing, Liang Li, Wentao Huang, et al.. (2015). MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial–mesenchymal transition. Cancer Letters. 364(1). 33–43. 52 indexed citations
19.
Wendt, Daniel, Guojun Hou, Matthias Thielmann, et al.. (2011). Development and In Vitro Characterization of a New Artificial Flow Channel. Artificial Organs. 35(3). E59–64. 5 indexed citations
20.
Wendt, Daniel, et al.. (2011). Fluid Dynamic Investigation of the ATS 3F Enable Sutureless Heart Valve. Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery. 6(1). 37–44. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvie Fabre Breakdown of academic impact, for papers by Diego Quinones Raffo Breakdown of academic impact, for papers by Indu Raman Breakdown of academic impact, for papers by Tarek I. Ahmed Breakdown of academic impact, for papers by Marta Vidal Breakdown of academic impact, for papers by Amar Bhatnagar Breakdown of academic impact, for papers by Andrew Podd Breakdown of academic impact, for papers by Seiji Segawa Breakdown of academic impact, for papers by Simanta Pathak Breakdown of academic impact, for papers by Norzawani B Buang
Rankless by CCL
2026